The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado BPC 157 Banned: Key Facts on the Latest FDA Decision Is BPC 157 Legal? Understanding Its Status and Implications FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Frontiers Syzygium aromaticum (clove buds) as a natural antibacterial agent: a promising alternative to combat multidrug resistant bacteria